Target intelligence / Profile preview

Central nervous system neurotransmission

Molecular classification
Other
01

Overview

"Central nervous system neurotransmission" is not a specific molecule, receptor, or protein but rather refers to the overall process by which neurons in the central nervous system (CNS) communicate with each other using chemical messengers called neurotransmitters. This process involves a wide variety of molecules—including amino acids (e.g., glutamate, GABA), monoamines (e.g., dopamine, serotonin), peptides (e.g., substance P), purines (e.g., ATP), and others—that are released from presynaptic neurons and bind to specific receptors on postsynaptic cells to modulate neuronal activity[1][3][4][5]. The term encompasses multiple molecular targets such as receptors, transporters, enzymes involved in synthesis and degradation of neurotransmitters, and ion channels. Because it is not a single defined target but an umbrella term for many different molecular systems within the CNS, "central nervous system neurotransmission" should not be considered a canonical therapeutic target itself; instead, individual components of this process—such as "gamma-aminobutyric acid type A receptor," "dopamine transporter," or "acetylcholinesterase"—are valid drug targets[1][3][4]. There is something incorrect with this entry because it lacks specificity; it does not refer to any one molecule or receptor but rather describes an entire physiological process involving numerous distinct targets.

02

Biological functions

Signal transductionSynaptic transmission
03

Disease associations

Neurodegenerative diseasePsychiatric disorder

Beyond the preview

Go deeper on Central nervous system neurotransmission.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central nervous system neurotransmission.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call